Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Emily Feneberg

MD, DPhil

Clinical Postdoctoral Fellow

  • Guarantors of Brain Clinical Post Doctoral Fellow
  • Past MRC/ MNDA Lady Edith Wolfson Clinical Research Training Fellow

Emily is a neurologist who has completed her DPhil about "TDP-43 based biomarker development in amyotrophic lateral sclerosis" at the Oxford Motor Neuron Disease Center.

At Professor’s Turner lab she is researching TDP-43 the main pathological protein involved in Amyotrophic lateral sclerosis (ALS) and Frontotemporal dementia (FTD) to detect its pathological forms and protein interactors in patients’ biofluids, human post-mortem tissue and ALS disease models. Her aim is to develop a disease-specific biomarker for ALS and FTD for the better management of those diseases.

During her medical studies at the University of Leipzig, Germany, she also completed her thesis on experimental Alzheimer's disease. She undertook her neurology training at the University Hospital of Ulm, focusing on biomarker research in ALS and FTD.

Key publications

Recent publications

More publications